2 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Conjunctivitis: new trials by email Literature Review of Conjunctivitis trials Research Report on Conjunctivitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical rVA576 for Treatment of Atopic Keratoconjunctivitis rVA576, Placebo - Keratoconjunctivitis, Atopic, Keratoconjunctivitis, Vernal | Phase 1 / Phase 2 | Terminated | AKARI Therapeutics | 12 | 2019-03-04 | 2025-04-10 |
| Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections Dose Level 1, Dose Level 2, Placebo - Allergic Conjunctivitis, Allergic Rhinitis | Phase 1 | Terminated | Woodmont Pharmaceuticals, Inc. | 2 | 2017-03-30 | 2018-02-26 |
Conjunctivitis, Allergic (2) · Keratoconjunctivitis (1) · Rhinitis, Allergic (1)
Conjunctival Diseases (2) · Eye Diseases (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Corneal Diseases (1) · Keratitis (1) · Nose Diseases (1) · Otorhinolaryngologic Diseases (1) · Respiratory Hypersensitivity (1) · Respiratory Tract Diseases (1) · Rhinitis (1)
AKARI Therapeutics (1) · Woodmont Pharmaceuticals, Inc. (1)
Spain (1) · United Kingdom (1) · United States (1)
Emily Schoemmell (1) · Sajjad Ahmad (1)